Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review
- PMID: 29391289
- DOI: 10.1016/j.jtho.2018.01.017
Immunological Aspects of Cryoablation of Non-Small Cell Lung Cancer: A Comprehensive Review
Abstract
In cryoimmunotherapy, target tumors are treated with cryoablation to generate antitumor immune responses. Because immune checkpoint inhibitors have demonstrated that lung cancer can be an immunotherapy-responsive disease, there has been renewed interest in the immunological aspects of cryoablation of lung cancer. Herein, we review preclinical and clinical trials of cryoablation of primary lung tumors. We examine the magnitude of cryoablation-induced antitumor immune responses and the synergy between cryoablation and either other immunotherapies or molecular targeted therapies to improve treatment responses in advanced lung cancer. We further discuss a rationale for the addition of cryoablation to immune checkpoint inhibitors for the treatment of advanced lung cancer, which is currently under clinical investigation.
Keywords: Cryoablation; Cryoimmunotherapy; Cryotherapy; Lung cancer.
Copyright © 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.Immunol Res. 2017 Aug;65(4):880-887. doi: 10.1007/s12026-017-8927-x. Immunol Res. 2017. PMID: 28508945 Clinical Trial.
-
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.Cancer Immunol Immunother. 2014 Apr;63(4):369-80. doi: 10.1007/s00262-014-1520-4. Epub 2014 Jan 23. Cancer Immunol Immunother. 2014. PMID: 24452202 Free PMC article.
-
Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.Cryobiology. 2013 Oct;67(2):235-40. doi: 10.1016/j.cryobiol.2013.08.001. Epub 2013 Aug 13. Cryobiology. 2013. PMID: 23948179
-
Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.Expert Opin Biol Ther. 2016 Oct;16(10):1209-23. doi: 10.1080/14712598.2016.1214265. Epub 2016 Aug 5. Expert Opin Biol Ther. 2016. PMID: 27426430 Review.
-
Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.Clin Cancer Res. 2015 Mar 1;21(5):976-84. doi: 10.1158/1078-0432.CCR-14-1187. Clin Cancer Res. 2015. PMID: 25733707 Review.
Cited by
-
Image-guided percutaneous ablation for lung malignancies.Front Oncol. 2022 Nov 10;12:1020296. doi: 10.3389/fonc.2022.1020296. eCollection 2022. Front Oncol. 2022. PMID: 36439490 Free PMC article. Review.
-
Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors.Transl Lung Cancer Res. 2021 Jun;10(6):2842-2857. doi: 10.21037/tlcr-20-1075. Transl Lung Cancer Res. 2021. PMID: 34295682 Free PMC article. Review.
-
Freezing biological organisms for biomedical applications.Smart Med. 2022 Dec 27;1(1):e20220034. doi: 10.1002/SMMD.20220034. eCollection 2022 Dec. Smart Med. 2022. PMID: 39188743 Free PMC article. Review.
-
Investigation of Lung Cancer Cell Response to Cryoablation and Adjunctive Gemcitabine-Based Cryo-Chemotherapy Using the A549 Cell Line.Biomedicines. 2024 Jun 3;12(6):1239. doi: 10.3390/biomedicines12061239. Biomedicines. 2024. PMID: 38927445 Free PMC article.
-
[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors].Zhongguo Fei Ai Za Zhi. 2022 Apr 20;25(4):266-271. doi: 10.3779/j.issn.1009-3419.2022.102.09. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35477191 Free PMC article. Review. Chinese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
